StockDuty ← Dashboard Nov 04, 2026 01:42 AM ET
SignalCorporate

CeriBell outlines $115M-$117M 2026 revenue, while launching delirium monitoring and previewing Omni for 2027

CeriBell outlines $115M-$117M 2026 revenue, while launching delirium monitoring and previewing Omni for 2027

What happened: CeriBell outlined 2026 revenue guidance of $115M to $117M, said it is launching delirium monitoring, and previewed Omni for 2027. Key numbers: Q3 revenue $29.3 million, up approximately 30% year-over-year. 2026 revenue guidance $115M to $117M. Why it matters: Management tied the quarter to adoption and commercial execution, and the guidance plus new product launches point to planned expansion beyond the current portfolio.
CeriBell outlined 2026 revenue guidance of $115M to $117M, said it is launching delirium monitoring, and previewed Omni for 2027.
Management tied the quarter to adoption and commercial execution, and the guidance plus new product launches point to planned expansion beyond the current portfolio.
Sources